491 related articles for article (PubMed ID: 33167048)
1. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme.
Akhter MH; Rizwanullah M; Ahmad J; Amin S; Ahmad MZ; Minhaj MA; Mujtaba MA; Ali J
Drug Res (Stuttg); 2021 Mar; 71(3):122-137. PubMed ID: 33167048
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
3. Use of nanoparticles for glioblastoma treatment: a new approach.
Játiva P; Ceña V
Nanomedicine (Lond); 2017 Oct; 12(20):2533-2554. PubMed ID: 28952878
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.
Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J
Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.
Baumann BC; Kao GD; Mahmud A; Harada T; Swift J; Chapman C; Xu X; Discher DE; Dorsey JF
Oncotarget; 2013 Jan; 4(1):64-79. PubMed ID: 23296073
[TBL] [Abstract][Full Text] [Related]
7. Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice.
Qin H; Jiang Y; Zhang J; Deng C; Zhong Z
Mol Pharm; 2019 Aug; 16(8):3711-3719. PubMed ID: 31299161
[TBL] [Abstract][Full Text] [Related]
8. Gene Therapy for Drug-Resistant Glioblastoma via Lipid-Polymer Hybrid Nanoparticles Combined with Focused Ultrasound.
Yang Q; Zhou Y; Chen J; Huang N; Wang Z; Cheng Y
Int J Nanomedicine; 2021; 16():185-199. PubMed ID: 33447034
[TBL] [Abstract][Full Text] [Related]
9. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
Rezaei V; Rabiee A; Khademi F
J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871
[TBL] [Abstract][Full Text] [Related]
11. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
12. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
13. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme.
Ortega-Berlanga B; Gonzalez C; Navarro-Tovar G
Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):8. PubMed ID: 33772646
[TBL] [Abstract][Full Text] [Related]
15. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.
Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE
Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
[TBL] [Abstract][Full Text] [Related]
18. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
[TBL] [Abstract][Full Text] [Related]
19. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.
Wadhwa K; Chauhan P; Kumar S; Pahwa R; Verma R; Goyal R; Singh G; Sharma A; Rao N; Kaushik D
Oncol Res; 2024; 32(5):877-897. PubMed ID: 38686045
[TBL] [Abstract][Full Text] [Related]
20. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
